U.S. flag

An official website of the United States government

NM_001267550.2(TTN):c.26762-10_26762-9insTTGTTTTGTA AND not specified

Germline classification:
Benign/Likely benign (3 submissions)
Last evaluated:
Aug 14, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000480310.10

Allele description [Variation Report for NM_001267550.2(TTN):c.26762-10_26762-9insTTGTTTTGTA]

NM_001267550.2(TTN):c.26762-10_26762-9insTTGTTTTGTA

Gene:
TTN:titin [Gene - OMIM - HGNC]
Variant type:
Insertion
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.26762-10_26762-9insTTGTTTTGTA
HGVS:
  • NC_000002.12:g.178713385_178713386insTACAAAACAA
  • NG_011618.3:g.122421_122422insTTTGTATTGT
  • NM_001256850.1:c.25811-10_25811-9insTTGTTTTGTA
  • NM_001267550.2:c.26762-10_26762-9insTTGTTTTGTAMANE SELECT
  • NM_003319.4:c.13282+24700_13282+24701insTTGTTTTGTA
  • NM_133378.4:c.23030-10_23030-9insTTGTTTTGTA
  • NM_133432.3:c.13657+24700_13657+24701insTTGTTTTGTA
  • NM_133437.4:c.13858+24700_13858+24701insTTGTTTTGTA
  • LRG_391:g.122421_122422insTTTGTATTGT
  • NC_000002.11:g.179578108_179578109insACAATACAAA
  • NC_000002.11:g.179578112_179578113insTACAAAACAA
  • NM_001256850.1:c.25811-10_25811-9insTTTGTATTGT
  • NM_001267550.2:c.26762-10_26762-9insTTTGTATTGTMANE SELECT
  • NM_133378.4:c.23030-10_23030-9insTTTGTATTGT
Links:
dbSNP: rs1553893826
NCBI 1000 Genomes Browser:
rs1553893826
Molecular consequence:
  • NM_001256850.1:c.25811-10_25811-9insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001267550.2:c.26762-10_26762-9insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_003319.4:c.13282+24700_13282+24701insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133378.4:c.23030-10_23030-9insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133432.3:c.13657+24700_13657+24701insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_133437.4:c.13858+24700_13858+24701insTTGTTTTGTA - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000568172GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely benign
(Dec 28, 2017)
germlineclinical testing

Citation Link,

SCV000597667Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Dec 23, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004039494Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Benign
(Aug 14, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From GeneDx, SCV000568172.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV000597667.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004039494.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: TTN c.23030-10_23030-9insTTTGTATTGT results in the insertion of 10 nucleotides at a position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: four predict the variant weakens a 3' acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00037 in 149680 control chromosomes (i.e., 55 heterozygotes), predominantly at a frequency of 0.00053 within the Non-Finnish European subpopulation in the gnomAD database (v3.1.2). The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 1.4 fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. To our knowledge, no occurrence of c.23030-10_23030-9insTTTGTATTGT in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Four submitters have reported clinical-significance assessments for this variant to ClinVar after 2014; three submitters classified the variant as likely benign, and one submitter classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2024